Using a stem cell technique for sperm creation, scientists have created healthy offspring from genetically infertile male mice, offering a potential new approach to tackling a common genetic cause of human infertility.
Our sex is determined by the X and Y chromosomes. Usually, girls have two X chromosomes (XX) and boys have one X and one Y (XY), but approximately one in 500 boys are born with an extra X or Y.
Having three rather than two sex chromosomes can disrupt formation of mature sperm and cause infertility.
In a study published in the journal Science, scientists at Francis Crick Institute in London and Kyoto University in Japan described a way to remove the extra sex chromosome to produce fertile offspring.
If the findings can be safely transferred into humans, it might eventually be possible for men with Klinefelter syndrome (XXY) or Double Y syndrome (XYY) who are infertile to have children through assisted reproduction using this technique.
"Our approach allowed us to create offspring from sterile XXY and XYY mice," said first author Takayuki Hirota from the Francis Crick Institute.
"It would be interesting to see whether the same approach could one day be used as a fertility treatment for men with three sex chromosomes," Hirota said.
The team took small pieces of ear tissue from XXY and XYY mice, cultured them, and collected connective tissue cells known as fibroblasts.
They turned the fibroblasts into stem cells and noticed that in the process, some of the cells lost the extra sex chromosome.
With an existing method, they used specific chemical signals to 'guide' the stem cells into becoming cells that have the potential to become sperm.
These cells developed into mature sperm when injected into the testes of a host mouse.
The researchers then harvested these mature sperm and used them through assisted reproduction to create healthy, fertile offspring.
In a preliminary experiment, the team found that stem cells produced from fibroblasts of men with Klinefelter syndrome also lost the extra sex chromosome.
However, more research is needed before this approach could ever be used in humans, the researchers pointed out.
--IANS
gb/vm
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
